ClinicalTrials.govpublic full text
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
advanced solid tumors cancer, squamous cell carcinoma, head and neck squamous cell carcinoma, locally advanced head and neck squamous cell carcinoma, metastatic head and neck squamous cell carcinoma, cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 886616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.